NWU Institutional Repository

Antimalarial N-1,N-3-dialkyldioxonaphthoimidazoliums: synthesis, biological activity, and structure-activity relationships

dc.contributor.authorAhenkorah, Stephen
dc.contributor.authorHaynes, Richard
dc.contributor.authorCoertzen, Dina
dc.contributor.authorTong, Jie Xin
dc.contributor.authorFridianto, Kevin
dc.contributor.researchID22966390 - Haynes, Richard Kingston
dc.date.accessioned2020-04-30T09:22:38Z
dc.date.available2020-04-30T09:22:38Z
dc.date.issued2020
dc.description.abstractHere we report the nanomolar potencies of N1,N3-dialkyldioxonaphthoimidazoliums against asexual forms of sensitive and resistant Plasmodium falciparum. Activity was dependent on the presence of the fused quinone-imidazolium entity and lipophilicity imparted by the N1/N3 alkyl residues on the scaffold. Gametocytocidal activity was also detected, with most members active at IC50 < 1 μM. A representative analog with good solubility, limited PAMPA permeability, and microsomal stability demonstrated oral efficacy on a humanized mouse model of P. falciparumen_US
dc.identifier.citationAhenkorah, K. et al. 2020. Antimalarial N-1,N-3-dialkyldioxonaphthoimidazoliums: synthesis, biological activity, and structure-activity relationships. ACS medicinal chemistry letters, 11(1):49-55. [https://doi.org/10.1021/acsmedchemlett.9b00457]en_US
dc.identifier.issn1948-5875
dc.identifier.urihttp://hdl.handle.net/10394/34587
dc.identifier.urihttps://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.9b00457
dc.identifier.urihttps://doi.org/10.1021/acsmedchemlett.9b00457
dc.language.isoenen_US
dc.publisherACSen_US
dc.subjectAntimalarialsen_US
dc.subjectDioxonaphthoimidazoliumsen_US
dc.subjectQuinonesen_US
dc.subjectDrug resistant asexual parasitesen_US
dc.subjectGametocytocidal activityen_US
dc.titleAntimalarial N-1,N-3-dialkyldioxonaphthoimidazoliums: synthesis, biological activity, and structure-activity relationshipsen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.61 KB
Format:
Item-specific license agreed upon to submission
Description: